Author

Katy L. Swancutt

The University of Texas Southwestern Medical CenterORCID 0000-0002-8991-409XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Anthony J. DavisiD· 2 shared Brock J. SishciD· 2 shared Elizabeth M. AlvesiD· 2 shared James H. NicholsoniD· 2 shared Michael D. StoryiD· 2 shared Todd Anthony AguileraiD· 2 shared Adam RusekiD· 1 shared Angelica FacoettiiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anthony J. DavisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinoma

Katy L. Swancutt, Eslam A. Elghonaimy, James H. Nicholson, Laurentiu M. Pop, Brock J. Sishc, Elizabeth M. Alves, Cassandra Hamilton, Adam Rusek, Anthony J. Davis, Raquibul Hannan, Michael D. Story, Todd Anthony Aguilera

This study evaluates carbon ion therapy's effectiveness in pancreatic ductal adenocarcinoma, finding that immune stromal components reduce its efficacy in vivo compared to in vitro results.

Molecular Cancer Therapeutics · Oct 13, 2025Peer-reviewedCancer Biology

Defective Homologous Recombination and Genomic Instability Predict Increased Responsiveness to Carbon Ion Radiotherapy in Pancreatic Cancer

Brock J. Sishc, Janapriya Saha, Elizabeth M. Alves, Lianghao Ding, Huiming Lu, Shih-Ya Wang, Katy L. Swancutt, James H. Nicholson, Angelica Facoetti, Arnold Pompoš, Mario Ciocca, Todd Anthony Aguilera, Michael D. Story, Anthony J. Davis

This study identifies PDAC cell lines defective in homologous recombination or with high genomic instability as more responsive to carbon ion radiotherapy, suggesting potential for targeted therapy.

npj Precision Oncology · Jan 17, 2025Peer-reviewedCancer Biology